Artificial Intelligence (AI) In Respiratory Diseases Market Size In 2026: Growth Outlook And Forecast Through 2030
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Artificial Intelligence (AI) In Respiratory Diseases Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The artificial intelligence (AI) in respiratory diseases market size has shown consistent growth over recent years. It is anticipated to increase from $7.98 billion in 2025 to $8.38 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.9%. This past growth can be attributed to factors such as the escalating incidence of respiratory conditions, increased adoption of CT and MRI imaging techniques, the expanding digitalization of healthcare records, the early implementation of AI-assisted diagnostic tools, and the enhancement of diagnostic capabilities within hospitals.
The artificial intelligence (AI) in respiratory diseases market size is projected to experience robust expansion over the coming years. This market is set to reach $10.19 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.0%. This anticipated growth during the forecast period stems from factors such as the increasing need for individualized respiratory care, the growing incorporation of AI into clinical decision support systems, the expansion of remote monitoring for patients with chronic respiratory conditions, a heightened emphasis on preventive pulmonology, and innovations in medical imaging AI. Key developments expected within this period encompass the escalating utilization of AI-based imaging analysis, the rising implementation of models for predicting disease progression, the broader integration of AI in pulmonary diagnostics, the proliferation of remote respiratory monitoring solutions, and an intensified focus on identifying diseases early.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Intelligence (AI) In Respiratory Diseases Market Growth Momentum: What Factors Are Shaping Demand?
The trajectory of the respiratory disease market ahead. Environmental contamination describes the introduction of any material or energy form into the surrounding environment at a speed surpassing its ability to be harmlessly disseminated or retained. Artificial intelligence (AI) in respiratory diseases offers a substantial capability to lessen the impact of environmental pollution on respiratory health through features like continuous observation, individualized risk assessments, well-informed decision-making, and innovative remedies for both individuals and communities. For example, in November 2024, according to the Global Carbon Budget, a Japan-based annual scientific assessment, fossil carbon dioxide emissions climbed to 37.4 billion tonnes, an increase of 0.8% over the previous year. Consequently, escalating environmental pollution is stimulating the expansion of artificial intelligence (AI) within the respiratory disease market.
Artificial Intelligence (AI) In Respiratory Diseases Market Segment Landscape And Growth Outlook
The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –
1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection
3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments
Artificial Intelligence (AI) In Respiratory Diseases Market Trends Redefining Industry Growth
Leading companies in the artificial intelligence (AI) in the respiratory diseases market are innovating products like N-Tidal devices to track patients’ tidal breathing. The N-Tidal device assesses the volume of air moved during normal respiration, supplying significant data on lung performance. For example, in August 2023, TidalSense, a UK-based respiratory technology enterprise, released N-Tidal, a regulated AI solution for chronic obstructive pulmonary disease (COPD) diagnosis and handling. This technology merges N-Tidal’s CO2 sensor data with an artificial intelligence platform to gauge shifts in lung function, aiming to refine the diagnosis and management of this respiratory ailment. Clinical research has confirmed the technology’s high precision, and it is projected to revolutionize the diagnostic approach for respiratory conditions. This introduction marks a key progression in applying AI for respiratory disease evaluation, providing a more convenient and effective option than current diagnostic examinations.
Artificial Intelligence (AI) In Respiratory Diseases Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the artificial intelligence (AI) in respiratory diseases market are Siemens Healthineers, Philips Healthcare, GE Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Swaasa AI, VIDA Diagnostics Inc., Enlitic, Thirona B.V., ArtiQ, Icometrix, Aidence, Arterys, PneumoWave Ltd
View The Full Artificial Intelligence (AI) In Respiratory Diseases Market Report:
Artificial Intelligence (AI) In Respiratory Diseases Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
